Does a patient with suppressed thyroid‑stimulating hormone, elevated free thyroxine, negative thyroid‑stimulating immunoglobulin, and positive thyroid peroxidase antibodies have Graves disease?

Diagnostic Interpretation: Not Classic Graves' Disease

This presentation with suppressed TSH, elevated free T4, negative TSI, and positive TPO antibodies is NOT typical Graves' disease and most likely represents destructive thyroiditis (possibly Hashimoto's thyroiditis with thyrotoxicosis) or an atypical autoimmune thyroid disorder. 1

Diagnostic Reasoning

Why This is Likely NOT Graves' Disease

The absence of TSH receptor antibodies (TSI/TRAb) argues strongly against Graves' disease as the primary diagnosis. Current guidelines emphasize that anti-TSH-R antibody assays have sensitivity and specificity approaching 100% for Graves' disease 1. When these antibodies are negative, guidelines specifically recommend checking anti-TPO antibodies to assess for autoimmune thyroiditis instead 1.

Alternative Diagnosis: Destructive Thyroiditis

The combination of:

• Suppressed TSH with elevated free T4 (thyrotoxicosis)
• Negative TSI/TRAb (rules out stimulatory antibodies)
• Positive TPO antibodies (indicates autoimmune thyroiditis)

This pattern is most consistent with destructive thyroiditis associated with Hashimoto's thyroiditis (historically termed "hashitoxicosis") 2. This represents thyroid hormone release from gland destruction rather than stimulated overproduction.

Critical Next Steps

Essential Diagnostic Tests

1. Radioactive iodine uptake (RAIU) scan - This is the definitive test to distinguish:

   • Low/suppressed uptake → Destructive thyroiditis (thyroid hormone leaking from damaged gland)
   • High uptake → Stimulatory hyperthyroidism (would suggest Graves' despite negative antibodies)

2. Thyroid ultrasound with Doppler - Look for:

   • Heterogeneous echotexture with hypoechoic areas → Hashimoto's thyroiditis
   • Diffuse hypervascularity ("thyroid inferno") → Would suggest Graves' disease 3

Important Caveats

Beware of rare scenarios:

• TSI-negative Graves' disease exists but is uncommon 3, 4. Some patients have bioactive TSH receptor antibodies that don't register on standard TSI assays, though this represents a small minority.

• Seroconversion can occur - Approximately 40% of initially TSI-negative cases may develop positive antibodies during follow-up 2, suggesting immune overlap rather than true Graves' disease.

• Do NOT start antithyroid drugs empirically without confirming the diagnosis. In destructive thyroiditis, antithyroid drugs (methimazole/PTU) are ineffective and potentially harmful, as they block hormone synthesis but cannot stop hormone release from gland destruction 2. This mismanagement occurred in 80% of misdiagnosed cases and accelerated progression to hypothyroidism 2.

Management Algorithm

If RAIU is LOW (most likely scenario):

• Diagnosis: Destructive thyroiditis
• Treatment: Symptomatic management only
  • Beta-blockers for symptom control (palpitations, tremor)
  • NO antithyroid drugs
  • Monitor thyroid function every 4-6 weeks
  • Expect spontaneous resolution followed by hypothyroidism requiring levothyroxine replacement 2

If RAIU is HIGH (unexpected but possible):

• Diagnosis: Atypical Graves' disease with false-negative TSI
• Treatment: Standard Graves' management 5
  • Methimazole as first-line antithyroid drug
  • Consider radioactive iodine or surgery for definitive treatment
  • Repeat TSI/TRAb testing (may become positive) 3

The key principle: Never treat thyrotoxicosis with antithyroid drugs without confirming stimulatory hyperthyroidism through either positive TSI/TRAb or elevated RAIU. 1, 2